230 related articles for article (PubMed ID: 8932329)
21. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
Fuchs O
Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
[TBL] [Abstract][Full Text] [Related]
22. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.
Perkins AS; Fishel R; Jenkins NA; Copeland NG
Mol Cell Biol; 1991 May; 11(5):2665-74. PubMed ID: 2017172
[TBL] [Abstract][Full Text] [Related]
23. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
Wieser R; Schreiner U; Rieder H; Pirc-Danoewinata H; Grüner H; Loncarevic IF; Fonatsch C
Haematologica; 2003 Jan; 88(1):25-30. PubMed ID: 12551823
[TBL] [Abstract][Full Text] [Related]
24. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; van Putten WL; Valk PJ; van der Poel-van de Luytgaarde S; Hack R; Slater R; Smit EM; Beverloo HB; Verhoef G; Verdonck LF; Ossenkoppele GJ; Sonneveld P; de Greef GE; Löwenberg B; Delwel R
Blood; 2003 Feb; 101(3):837-45. PubMed ID: 12393383
[TBL] [Abstract][Full Text] [Related]
25. [Molecular study of bone marrow chimerism and expression of EVI-1 gene as manifestations of minimal residual disease after bone marrow transplantation (BMT)].
Jółkowska J; Witt M
Med Wieku Rozwoj; 1999; 3(1):139-52. PubMed ID: 10910646
[TBL] [Abstract][Full Text] [Related]
26. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
[TBL] [Abstract][Full Text] [Related]
27. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer.
Jazaeri AA; Ferriss JS; Bryant JL; Dalton MS; Dutta A
Gynecol Oncol; 2010 Aug; 118(2):189-95. PubMed ID: 20462630
[TBL] [Abstract][Full Text] [Related]
29. EVI1 splice variants modulate functional responses in ovarian cancer cells.
Dutta P; Bui T; Bauckman KA; Keyomarsi K; Mills GB; Nanjundan M
Mol Oncol; 2013 Jun; 7(3):647-68. PubMed ID: 23517670
[TBL] [Abstract][Full Text] [Related]
30. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.
Morishita K; Parganas E; Matsugi T; Ihle JN
Mol Cell Biol; 1992 Jan; 12(1):183-9. PubMed ID: 1370341
[TBL] [Abstract][Full Text] [Related]
31. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
Sitailo S; Sood R; Barton K; Nucifora G
Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037
[TBL] [Abstract][Full Text] [Related]
32. The transcription factor Evi-1.
Hirai H
Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
[TBL] [Abstract][Full Text] [Related]
33. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
Kreider BL; Orkin SH; Ihle JN
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6454-8. PubMed ID: 8341654
[TBL] [Abstract][Full Text] [Related]
34. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
Oval J; Smedsrud M; Taetle R
Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
[TBL] [Abstract][Full Text] [Related]
35. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain.
Tanaka T; Nishida J; Mitani K; Ogawa S; Yazaki Y; Hirai H
J Biol Chem; 1994 Sep; 269(39):24020-6. PubMed ID: 7929053
[TBL] [Abstract][Full Text] [Related]
36. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
[TBL] [Abstract][Full Text] [Related]
37. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.
Nucifora G; Begy CR; Kobayashi H; Roulston D; Claxton D; Pedersen-Bjergaard J; Parganas E; Ihle JN; Rowley JD
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4004-8. PubMed ID: 8171026
[TBL] [Abstract][Full Text] [Related]
38. Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?
Breccia M; Petti MC; Ottaviani E; Mancini M; D'Elia GM; Mecarocci S; Alimena G
Br J Haematol; 2002 Aug; 118(2):438-41. PubMed ID: 12139729
[TBL] [Abstract][Full Text] [Related]
39. Evi-1 expression in Xenopus.
Mead PE; Parganas E; Ohtsuka S; Morishita K; Gamer L; Kuliyev E; Wright CV; Ihle JN
Gene Expr Patterns; 2005 Jun; 5(5):601-8. PubMed ID: 15905132
[TBL] [Abstract][Full Text] [Related]
40. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.
Bobadilla D; Enriquez EL; Alvarez G; Gaytan P; Smith D; Slovak ML
Br J Haematol; 2007 Mar; 136(6):806-13. PubMed ID: 17341266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]